Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia Research Letter

   

Authors:	Roeker, L. E.; Knorr, D. A.; Pessin, M. S.; Ramanathan, L. V.; Thompson, M. C.; Leslie, L. A.; Zelenetz, A. D.; Mato, A. R.
Title:	Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
Keywords:	adult; aged; aged, 80 and over; middle aged; genetics; metabolism; protein binding; virology; blood; immunology; severity of illness index; cellular immunity; immunoglobulin g; virus rna; pathogenicity; chronic lymphatic leukemia; leukemia, lymphocytic, chronic, b-cell; virus pneumonia; rna, viral; immunity, cellular; complication; neutralizing antibody; antibodies, neutralizing; pandemic; antibodies, viral; virus antibody; pneumonia, viral; very elderly; humans; human; male; female; coronavirus infections; nucleocapsid proteins; betacoronavirus; coronavirus infection; pandemics; nucleocapsid protein; nucleocapsid protein, coronavirus
Journal Title:	Leukemia
Volume:	34
Issue:	11
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Date Published:	2020-11-01
Start Page:	3047
End Page:	3049
Language:	English
DOI:	10.1038/s41375-020-01030-2
PUBMED:	32855439
PROVIDER:	scopus
PMCID:	PMC7450257
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089865130&doi=10.1038%2fs41375-020-01030-2&partnerID=40&md5=0b0e1f7a213219cc6be2ab69eb985b81
Notes:	Article -- Export Date: 1 December 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/173352